Rhythm Pharmaceuticals Inc.

RYTM | NASDAQ

Price Alert Chart Builder DCF Calculator

$105.02

-$5.66 (-5.11%)

At close: Nov 5, 2026, 4:00 PM ET

$105.00

-$0.02 (-0.02%)

After-hours: Nov 5, 2026, 5:08 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-196.54M	-260.6M	-184.68M	-181.12M	-69.61M	-134M
Depreciation & Amortization	1.34M	1.56M	1.76M	1.67M	1.16M	690K
Stock-Based Compensation	66.82M	39.68M	32.55M	19.83M	20.8M	17.46M
Other Working Capital	-7.82M	2.42M	4.38M	-13.26M	-15.15M	551K
Other Non-Cash Items	13.68M	94.9M	9.4M	5.91M	-250K	-234K
Deferred Income Tax	n/a	n/a	n/a	n/a	-100M	n/a
Change in Working Capital	-968K	10.58M	4.81M	-19.72M	1.9M	-5.9M
Operating Cash Flow	-115.68M	-113.88M	-136.16M	-173.43M	-146M	-121.98M
Capital Expenditures	-953K	n/a	-47K	-4.28M	-5.43M	-214K
Cash Acquisitions	n/a	n/a	n/a	4M	100M	n/a
Purchase of Investments	-348.67M	-268.31M	-354.92M	-251.94M	-524.97M	-86.87M
Sales Maturities Of Investments	252.47M	260.64M	354.97M	284.25M	361.25M	245.61M
Other Investing Acitivies	-40M	-40.5M	-5.67M	-4M	7M	n/a
Investing Cash Flow	-137.15M	-48.17M	-5.67M	28.03M	-62.16M	158.53M
Debt Repayment	n/a	-12.9M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	-3.97M	n/a	n/a	n/a	n/a
Other Financial Acitivies	-19.92M	12.87M	25.49M	82.72M	4.76M	2.01M
Financial Cash Flow	217.96M	191.24M	74.37M	213.83M	166.48M	2.01M
Net Cash Flow	-34.78M	29.19M	-67.6M	68.43M	-41.68M	38.56M
Free Cash Flow	-116.63M	-113.88M	-136.2M	-177.71M	-151.44M	-122.19M
Adj. Free Cash Flow	-183.45M	-153.56M	-168.76M	-197.54M	-172.24M	-139.65M
Maintenance CapEx	n/a	n/a	n/a	n/a	n/a	-214K
Growth CapEx	-953K	n/a	-47K	-4.28M	-5.43M	n/a
Owner Earnings	-115.68M	-113.88M	-136.16M	-173.43M	-146M	-122.19M